Who Should Attend
This educational activity is intended for oncologists, hematologists,
physicians, internists, and other healthcare professionals interested
in the management of hematologic malignancies.
Statement of Need
As the rate at which clinical data is released increases and the
numbers of therapeutic options grow, it is important for practicing
oncologists and hematologists to stay abreast of these advances. Many
community oncologists, hematologists and other physicians involved in
the management of hematologic malignancies do not attend major society
meetings and likewise those who do, find the size and scope to be so
broad and intensive that they require summaries of important data for
ease of application to their daily practices. In order for rapid
clinical progress to have a direct and immediate impact on patients’
lives, the newest findings must be readily applied by the practices of
community oncologists. In addition, the data presented at large
clinical conferences is typically not framed in the context of the
clinical practices of the community oncologists. PRIME Oncology
presents
“Hematologic Malignancies Demystified: The Series” A Critical Appraisal of Data from 2008 and ASH, to review, summarize, and interpret the most clinically significant data in an effort to meet this need.
Educational Objectives
Upon completion of this educational activity, participants should be better able to:
- Describe the latest management approaches for hematologic
malignancies including leukemia, lymphoma, multiple myeloma,
myelodysplastic syndromes and myeloproliferative disorders
- Explain difficult or unusual problems encountered by the practicing hematologist/oncologist
- Identify appropriate management options based on emerging data
- Discuss
issues surrounding the design and conduct of clinical trials that
incorporate novel agents and/or regimens for patients with hematologic
malignancies
- Summarize emerging data in the management of multiple hematologic malignancies
- Integrate new findings into clinical practice
